Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement
Single-Molecule DNA Sequencing System Promises Dramatic Improvement in Cost, Speed, Versatility, and Simplicity of Sequencing
14-Jan-2009 -
Illumina and Oxford Nanopore Technologies announced a strategic alliance including a commercialization agreement and equity investment. Under the terms of the commercialization agreement, Illumina will exclusively market, sell, distribute, and service BASE™ Technology products developed by Oxford ...
bases
DNA sequencing
labels
+1